US Stock MarketDetailed Quotes
TCRT Alaunos Therapeutics
- 3.8087
- -0.2713-6.65%
Close Jul 23 16:00 ET
- 3.9400
- +0.1313+3.45%
Post 19:54 ET
6.10MMarket Cap-226P/E (TTM)
4.0700High3.6315Low37.50KVolume4.0700Open4.0800Pre Close142.54KTurnover2.87%Turnover RatioLossP/E (Static)1.60MShares72.750052wk High1.27P/B4.98MFloat Cap3.631552wk Low--Dividend TTM1.31MShs Float36000.0000Historical High--Div YieldTTM10.75%Amplitude3.6315Historical Low3.8000Avg Price1Lot Size
About Alaunos Therapeutics Company
ZIOPHARM Oncology, Inc. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of immuno-oncology platforms that leverage cell- and gene-based therapies to treat patients with cancer. Its pipeline includes Sleeping Beauty TCR-T Targeting neoantigens; Ad-RTS-hlL-12 + veledimex; and Sleeping Beauty CAR-T. The company was founded on September 9, 2003 and is headquartered in Boston, MA.
Company Profile
SymbolTCRT
Company NameAlaunos Therapeutics
Listing DateSep 22, 2006
Founded2003
CEOMr. Dale Curtis Hogue, Jr
MarketNASDAQ
Employees1
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
AddressNavy Yard Plaza,1 First Avenue,Parris Building 34, 3rd floor
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02129
Phone1-617-259-1970
Websitehttp://www.ziopharm.com
Company Executives
- Name
- Position
- Salary
- Dale Curtis Hogue, Jr
- Director and Interim Chief Executive Officer
- 11.09K
- Ferdinand Groenewald
- Vice President, Finance
- --
- Holger Weis
- Chairman of the Board
- 900.26K
- Jaime Vieser
- Independent Director
- 103.26K
- Dr. Robert J Hofmeister, PhD
- Independent Director
- 84.01K
- Robert W. Postma
- Independent Director
- 104.26K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg